Elevance Health, Inc. (ELV) is set to report its fourth-quarter 2023 results on Jan 24, before the opening bell. This time around, the company’s overall earnings performance is likely to have received a boost from higher segmental profits, only to be undone by reduced total medical memberships and higher costs.What Do the Estimates Say?The Zacks Consensus Estimate for fourth-quarter earnings per share of $5.55 suggests a 6.1% increase from the prior-year figure of $5.23. The consensus mark remained stable o ...